211 related articles for article (PubMed ID: 16326885)
1. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study.
Howie C; Hughes H; Watts AC
J Bone Joint Surg Br; 2005 Dec; 87(12):1675-80. PubMed ID: 16326885
[TBL] [Abstract][Full Text] [Related]
2. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.
Pellegrini VD; Donaldson CT; Farber DC; Lehman EB; Evarts CM
Clin Orthop Relat Res; 2006 Nov; 452():21-7. PubMed ID: 16906107
[TBL] [Abstract][Full Text] [Related]
3. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.
Warwick D; Friedman RJ; Agnelli G; Gil-Garay E; Johnson K; FitzGerald G; Turibio FM
J Bone Joint Surg Br; 2007 Jun; 89(6):799-807. PubMed ID: 17613508
[TBL] [Abstract][Full Text] [Related]
4. Frequency and timing of clinical venous thromboembolism after major joint surgery.
Bjørnarå BT; Gudmundsen TE; Dahl OE
J Bone Joint Surg Br; 2006 Mar; 88(3):386-91. PubMed ID: 16498018
[TBL] [Abstract][Full Text] [Related]
5. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism associated with hip and knee replacement over a ten-year period.
Kong KC
J Bone Joint Surg Br; 2006 Feb; 88(2):277. PubMed ID: 16434541
[No Abstract] [Full Text] [Related]
8. [Venous thromboembolism prophylaxis after total hip arthroplasty].
Kučera T; Malý R; Urban K; Sponer P
Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
[TBL] [Abstract][Full Text] [Related]
10. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism associated with hip and knee replacement over a ten-year period.
Kong KC
J Bone Joint Surg Br; 2006 Mar; 88(3):416. PubMed ID: 16498027
[No Abstract] [Full Text] [Related]
12. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
[TBL] [Abstract][Full Text] [Related]
13. A mobile compression device for thrombosis prevention in hip and knee arthroplasty.
Colwell CW; Froimson MI; Anseth SD; Giori NJ; Hamilton WG; Barrack RL; Buehler KC; Mont MA; Padgett DE; Pulido PA; Barnes CL
J Bone Joint Surg Am; 2014 Feb; 96(3):177-83. PubMed ID: 24500578
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism following primary total knee arthroplasty.
Hitos K; Fletcher JP
Int Angiol; 2006 Dec; 25(4):343-51. PubMed ID: 17164739
[TBL] [Abstract][Full Text] [Related]
15. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
16. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
Kwong LM
Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
[TBL] [Abstract][Full Text] [Related]
18. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
Colwell CW
Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
[TBL] [Abstract][Full Text] [Related]
19. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
20. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
Kerr J; Linkins LA
Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
